NCT04475094 - Impact of Coronary Artery Stenting on Quantitative Myocardial Blood Flow and Health Status | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Coronary Artery Disease

Interventions

DRUG

Rubidium-82

Consented subjects will undergo a rest/regadenoson stress myocardial perfusion PET study.

BEHAVIORAL

Seattle Angina Questionnaire-7

Consented subjects will complete a SAQ-7.

BEHAVIORAL

Rose Dyspnea Scale

Consented subjects will complete a RDS.

Trial Locations (1)

RECRUITING

Saint Luke's Hospital Imaging Center, Kansas City